CANNAINVESTOR Magazine September / October 2016 - Page 38

Through Dr. Cindy Orser’s work with Nevada state officials, Digipath pioneered cannabis lab testing protocols in Nevada’s implementation of the nation’s most stringent policies on cannabis safety, which has positioned the company as a market leader in cannabis lab testing. Through the Company’s invaluable experience in Nevada, Digipath has developed a greater understanding of the nuanced needs of the industry as well as an ability to navigate the complex regulatory environment at the state level regarding cannabis testing. States nationwide are looking to develop lab testing policies similar to Nevada’s stringent requirements, which create demand for qualified laboratories to perform such testing, both to assist producers of cannabis and cannabis products to meet expected state mandated requirements and to provide assurance to consumers regarding the safety and composition of such products.

The Digipath Certified Seal – A Mark of Confidence

The Company offers comprehensive medical cannabis safety screening and an independent certification system, including the “Digipath Labs Certified” certification seal. This seal is identified by labels and stickers provided to participating dispensaries and growers so they may better self-regulate their processes in order to assure safe and clean medicines and to advance the cause of cannabis therapeutics. Independent testing reduces the risks of contamination and thereby improves the overall quality of the cannabis distributed as medicine through the dispensaries.

Digipath’s certification program helps medical cannabis patients know the quality of the cannabis they are using as medicine. The Digipath Certified Seal assures the patient that their products are pure, pesticide-free, and properly measured for potency. With the Digipath Certified Seal and certification program, growers can ensure quality and improve their operations. Advocates, patients, dispensaries, and growers all benefit from testing that helps to legitimize medical cannabis. Rather than suffering a quality crisis that fuels the opposition, the medical cannabis industry can thrive in an atmosphere of self-regulation and control as testing ensures that the medicines are safe and effective.

Comprehensive Cannabis Testing for Greatest Quality Assurance and Consumer Safety

Digipath Labs screens medicinal cannabis and cannabis-based products for both potency and quality for potentially harmful contaminants, including:

•Residual solvents (for non-CO2 extracts)


•Heavy metals (including mercury, arsenic, lead, and cadmium)

•Biological toxins (including the mycotoxins: aflatoxins and ocratoxin A)

•Microbial contaminants including:

-pathogenic E. coli,

-pathogenic Salmonella spp.

-Total Yeast & Mold (TYM)

-Total Aerobic Count (TAC)